The North America Electrophoresis Market was valued at USD 1,135 Million in 2025 and is expected to reach USD 2,590 Million by 2035, expanding at a CAGR of 7.7% from 2024 to 2035. This market study covers industry drivers, trends, key opportunities, and recent developments, providing comprehensive insights into the evolving landscape of electrophoresis in North America.
The economic impact of tariffs on "North America Electrophoresis Market".
North America Electrophoresis Market Growth Drivers
Rising Demand for Genomic and Proteomic Research: The increasing investment in genomics and proteomics, mainly driven by initiatives from both public and private sectors, is stimulating the demand for advanced electrophoresis systems. Companies like Bio-Rad Laboratories, Inc. are continually innovating their product portfolios to support large-scale DNA, RNA, and protein testing. This technological advancement, combined with growing adoption in clinical diagnostics, forensic analysis, and biotechnology research, is powering the market expansion.
Advancements in Automated Electrophoresis Systems: Automation in electrophoresis technology is enabling higher throughput and improved accuracy in laboratories. Thermo Fisher Scientific has recently launched automated systems that reduce manual intervention and minimize human error, making these solutions attractive to research institutions and diagnostic centers. These innovations are accelerating adoption, especially as laboratories seek efficiency and scalability.
North America Electrophoresis Market Trends
Integration with Digital Solutions and Data Analytics: There is a growing trend of integrating electrophoresis systems with digital platforms for enhanced data analysis and management. Companies like Agilent Technologies are focusing on cloud-enabled electrophoresis instruments that allow real-time data sharing and remote monitoring. This not only improves workflow efficiency but also supports collaboration across research facilities.
Shift Towards Capillary Electrophoresis: Capillary electrophoresis is gaining popularity due to its superior speed, sensitivity, and reduced reagent consumption. Healthcare and pharmaceutical companies in the region are increasingly adopting capillary electrophoresis for drug purity analysis and biomarker discovery. For instance, SCIEX (a Danaher Corporation company) has reported increased uptake of its capillary electrophoresis systems among clinical research labs.
North America Electrophoresis Market Opportunities
Expansion in Clinical Diagnostics: With the surge in personalized medicine and biomarker analysis, there is a substantial opportunity for electrophoresis applications in clinical diagnostics. Companies such as Helena Laboratories are working on expanding their clinical diagnostic electrophoresis kits for disease detection, particularly for cancer and neurological disorders.
Growth in Biopharmaceutical Manufacturing: The increasing approval and production of biosimilars and biologics open opportunities for electrophoresis in quality control and validation processes. Firms including GE Healthcare are exploring partnerships with biopharma manufacturers to co-develop electrophoresis-based drug characterization solutions.
North America Electrophoresis Market Revenue (USD Million), 2020-2035
The chart shows a consistent upward trend in the electrophoresis market from 2020 to 2035. Starting at USD 720 Million in 2020, the market demonstrates a strong compound annual growth rate, reaching USD 1,135 Million by 2025. The acceleration continues with an expected revenue of USD 2,590 Million by 2035. This rise is mainly attributed to the growing demand for molecular diagnostics, increased adoption of automation, and expansions in life science research throughout North America. The market’s steady growth reflects ongoing technological advancements and the widening scope of electrophoresis applications.
North America Electrophoresis Market by Region Share (%), 2025
The 2025 market share pie chart reveals that the United States holds the largest share of the North America electrophoresis market at 78%, reflecting its dominant presence in biotech research and healthcare. Canada follows with a significant share of 15%, benefiting from robust investment in life sciences. Mexico accounts for 5%, while the rest of North America and the Caribbean together hold the remaining 2%. These figures highlight the market’s concentration in the U.S., but also the growing importance of other regions in adopting advanced electrophoresis technologies.
Recent Developments in North America Electrophoresis Market
In February 2024, Bio-Rad Laboratories, Inc. introduced its new compact electrophoresis instrument, the ChemiDoc Touch, for rapid gel imaging. This launch supports precise and high-throughput protein and nucleic acid analysis in research and clinical laboratories, targeting broad-scale life science adoption.
Thermo Fisher Scientific announced, in March 2024, a strategic partnership with a major academic medical center in the U.S. to deploy automated electrophoresis platforms. The collaboration aims to streamline genetic and proteomic testing workflows across multiple facilities, thereby accelerating diagnostic testing and research.
In April 2024, Agilent Technologies expanded its existing portfolio by launching a new cloud-integrated capillary electrophoresis system tailored for pharmaceutical quality assurance labs. The new system features enhanced connectivity for secure data access and is expected to boost efficiency in pharmaceutical product validation.
Press Releases